Sunshine Biopharma (SBFMW) Return on Invested Capital (2022 - 2026)

Sunshine Biopharma has reported Return on Invested Capital for 5 years, with the latest figure at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.07% in Q3 2025, with the low at 0.02% in Q2 2025.
• Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
• The largest YoY upside for Return on Invested Capital was 8 bps in 2025 against a maximum downside of 2 bps in 2025.
• Sunshine Biopharma's Return on Invested Capital stood at 0.01% in 2022, then surged by 72 bps to 0.0% in 2023, then retreated by 18 bps to 0.0% in 2024, then advanced by 8 bps to 0.0% in 2025, then declined by 8 bps to 0.0% in 2026.
• The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.07% (Q3 2025), per Business Quant data.